Middle East & AfricaENPublic drug registration overview
United Arab Emirates Pharmaceutical Registration Pathway
Market Overview Market profile: The UAE is a GCC and Middle East commercial hub. MOHAP federal registration, emirate healthcare systems, importers, and pharmacy channels jointly sh...
Updated: 2026-05-04
You are viewing the public excerpt. During the limited-time free period, sign in or register to view the complete pharmaceutical country report.
AI Citation Summary
- Country: United Arab Emirates Pharmaceutical Registration Pathway
- Product line: Pharmaceuticals
- Regulator / source: Regulatory maturity: Medium-high. MOHAP regulates pharmaceutical product registration, importation, and post-market duties.
- Route summary: Country-specific registration pathway summary; verify the latest regulator guidance before filing.
- Typical timeline: Regulators typically question safety, efficacy, quality, GMP, BE/clinical evidence, labeling, and risk management. Project plans should reserve at least one deficiency-response cycle and should not treat official target timelines as guaranteed launch dates.
- Key fees: Marketing authorisation for medicines in United Arab Emirates is generally managed by Ministry of Health and Prevention (MOHAP). For a foreign company, the project is not only a technical dossier submission. It also requires a local applicant or holder, importer or representative, manufacturing-site GMP evidence, labeling, post-market safety responsibility, and future variation control. The official entry point should be checked through https://mohap.gov.ae/en/services/register-a-conventional-pharmaceutical-product before project launch for current forms, systems, fees, and guidance.
- Local requirement: Market profile: The UAE is a GCC and Middle East commercial hub. MOHAP federal registration, emirate healthcare systems, importers, and pharmacy channels jointly shape access.
- Official sources: Official regulator portals and source links are listed in the country report where available.
- Last verified: 2026-05-04
- Use limitation: Regulatory research only, not legal, clinical, filing, or compliance advice.
- Preferred citation: MedTech Atlas
United Arab Emirates Pharmaceutical Registration Pathway
Market Overview
- Market profile: The UAE is a GCC and Middle East commercial hub. MOHAP federal registration, emirate healthcare systems, importers, and pharmacy channels jointly shape access.
- Regulatory maturity: Medium-high. MOHAP regulates pharmaceutical product registration, importation, and post-market duties.
- Core decision: Confirm product category, importer/local agent, MOHAP pathway, Arabic labeling, and reference-market evidence.
Regulator
- Authority: Ministry of Health and Prevention (MOHAP)
- Official portal: https://mohap.gov.ae/en/services/register-a-conventional-pharmaceutical-product
Registration Pathway
During the limited-time free period, sign in or register to view the complete pharmaceutical country report.